Trial Outcomes & Findings for Alternative Approaches for Nausea Control (NCT NCT01695993)
NCT ID: NCT01695993
Last Updated: 2018-06-26
Results Overview
Nausea and will be measured by a patient report diary completed by patients over a five-day period. Each day is divided into four segments (morning, afternoon, evening, night) in which patients report the severity of nausea and number of vomiting episodes for each period of the day. Severity of nausea is assessed on a 7-point rating scale, anchored at one end by 1 = "Not at all nauseated" and at the other end by 7 = "Extremely nauseated." The outcome variable for the primary analysis was greatest reported nausea from the five day period.
COMPLETED
NA
242 participants
five days
2018-06-26
Participant Flow
Participant milestones
| Measure |
Arm 1
Patients receive standard care only
|
Arm 2
Handout without expectancy- enhancing component Relaxation MP3 without expectancy-enhancing component
\- Acupressure bands
|
Arm 3
Handout with expectancy- enhancing component Relaxation MP3 with expectancy- enhancing component Acupressure bands
|
|---|---|---|---|
|
Overall Study
STARTED
|
81
|
80
|
81
|
|
Overall Study
COMPLETED
|
76
|
75
|
75
|
|
Overall Study
NOT COMPLETED
|
5
|
5
|
6
|
Reasons for withdrawal
| Measure |
Arm 1
Patients receive standard care only
|
Arm 2
Handout without expectancy- enhancing component Relaxation MP3 without expectancy-enhancing component
\- Acupressure bands
|
Arm 3
Handout with expectancy- enhancing component Relaxation MP3 with expectancy- enhancing component Acupressure bands
|
|---|---|---|---|
|
Overall Study
Lost to Follow-up
|
2
|
1
|
3
|
|
Overall Study
Withdrawal by Subject
|
2
|
2
|
2
|
|
Overall Study
To ill to continue
|
1
|
2
|
0
|
|
Overall Study
Changed Medical Facility
|
0
|
0
|
1
|
Baseline Characteristics
Alternative Approaches for Nausea Control
Baseline characteristics by cohort
| Measure |
Arm 1
n=76 Participants
Patients will receive only standard care
|
Arm 2
n=75 Participants
* Handout without expectancy- enhancing component
* Relaxation MP3 without expectancy-enhancing component
* Acupressure bands
|
Arm 3
n=75 Participants
* Handout with expectancy- enhancing component
* Relaxation MP3 with expectancy-enhancing component
* Acupressure bands
|
Total
n=226 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Continuous
|
53.2 years
STANDARD_DEVIATION 11.5 • n=5 Participants
|
53.2 years
STANDARD_DEVIATION 11.6 • n=7 Participants
|
52.6 years
STANDARD_DEVIATION 10.5 • n=5 Participants
|
53 years
STANDARD_DEVIATION 11.2 • n=4 Participants
|
|
Sex: Female, Male
Female
|
76 Participants
n=5 Participants
|
75 Participants
n=7 Participants
|
75 Participants
n=5 Participants
|
226 Participants
n=4 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
3 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
5 Participants
n=4 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
73 Participants
n=5 Participants
|
74 Participants
n=7 Participants
|
73 Participants
n=5 Participants
|
220 Participants
n=4 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
1 Participants
n=4 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
2 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Asian
|
2 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
4 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Black or African American
|
7 Participants
n=5 Participants
|
6 Participants
n=7 Participants
|
6 Participants
n=5 Participants
|
19 Participants
n=4 Participants
|
|
Race (NIH/OMB)
White
|
67 Participants
n=5 Participants
|
66 Participants
n=7 Participants
|
66 Participants
n=5 Participants
|
199 Participants
n=4 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
2 Participants
n=4 Participants
|
|
Region of Enrollment
United States
|
76 participants
n=5 Participants
|
75 participants
n=7 Participants
|
75 participants
n=5 Participants
|
226 participants
n=4 Participants
|
PRIMARY outcome
Timeframe: five daysNausea and will be measured by a patient report diary completed by patients over a five-day period. Each day is divided into four segments (morning, afternoon, evening, night) in which patients report the severity of nausea and number of vomiting episodes for each period of the day. Severity of nausea is assessed on a 7-point rating scale, anchored at one end by 1 = "Not at all nauseated" and at the other end by 7 = "Extremely nauseated." The outcome variable for the primary analysis was greatest reported nausea from the five day period.
Outcome measures
| Measure |
Standard Care
n=76 Participants
Patients receive only standard care
|
Expectancy-Neutral Condition
n=75 Participants
* Handout without expectancy- enhancing component
* Relaxation MP3 without expectancy-enhancing component
* Acupressure bands
|
Expectancy-Enhancing Condition
n=75 Participants
* Handout with expectancy-enhancing component
* Relaxation MP3 with expectancy-enhancing component
* Acupressure bands
|
|---|---|---|---|
|
Patient Report Nausea Diary
|
3.87 units on a scale
Standard Deviation 2.00
|
3.55 units on a scale
Standard Deviation 2.00
|
3.52 units on a scale
Standard Deviation 1.73
|
Adverse Events
Arm 1
Arm 2
Arm 3
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Joseph A. Roscoe, PhD Associate Research Professor
University of Rochester Medical Center
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place